A critical breakthrough in cancer research is emerging with the use of mini-antibodies to re-engage mutated p53. This crucial cancer inhibitor protein is frequently inactivated in various forms of cancer, resulting https://bookmarkingquest.com/story21871556/vhh-fragments-restore-p53-a-new-hope-for-malignant-therapy